NEW YORK, Oct. 27, 2016 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against National Beverage Corp. (“National Beverage” or the “Company”) (NASDAQ:FIZZ) and certain of its officers, on behalf of shareholders who purchased National Beverage securities from July 16, 2015 through September 28, 2016, both dates inclusive (the “Class Period”).
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that National Beverage lacked efficient internal controls over financial reporting, partially due to undisclosed expenses through off book entities and undisclosed material related parties transactions. Consequently, defendants’ statements regarding National Beverage’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
On September 28, 2016, Glaucus Research Group published a report revealing: (1) that FIZZ’s former CEO and Chairman confessed to "manipulating FIZZ's earnings . . . [and] directing his son to create fake invoices”; (2) that National Beverage refused "to allow a potential acquirer to perform adequate due diligence on the Company," which led to the failure of the transaction, (3) and that National Beverage's officers "are compensated by a privately held company" that disallows shareholder visibility; (4) that former counsel for the Company "testified that he and former FIZZ general counsel 'fudged facts' on behalf of FIZZ in a previous litigation"; (5) and that gifts of stock were not disclosed in the Company's SEC filings. Following this news, National Beverage stock dropped $3.81 per share, or 8.19%, to close at $42.67 on September 28, 2016.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/fizz or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in National Beverage you have until December 5, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
OpenAI Explores Massive Funding Round at $750 Billion Valuation
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 



